Cardiology Today Current Issue
The following articles appeared in the print edition of Cardiology Today.
Table of Contents
- New technologies advance treatment options for patients with arrhythmia disorders, HF Erik Swain
-
- Adding CRT to ICD therapy for mild HF can be cost-effective
- AF associated with elevated risk for dementia regardless of stroke
- Atrial fibrillation/flutter rare, increases complication risk in pregnant women with heart disease
- Black race, LV dysfunction linked to poorer outcomes of peripartum cardiomyopathy
- Cardiac rehabilitation referrals for HF slowly increasing
- Collaborative program lowers HF readmission rates
- CV risk factors, obesity common in women undergoing hysterectomy
- DANTE: Discontinuing antihypertensive medications did not improve cognitive function in elderly patients
-
- HARMONY: Ranolazine, dronedarone combination benefits patients with paroxysmal AF
- High resting heart rate linked to poor functional status in older adults
- Higher outdoor temperatures linked to lower BP
- Idarucizumab rapidly reverses anticoagulant effect of dabigatran, restores hemostasis
- ILUMIEN I: Pre-, post-PCI OCT findings influence physicians’ procedure strategies
- Intensive medical therapy controls risk factors, improves outcomes in diabetes, CHD
- Left, center of head most affected by radiation exposure during interventional procedures
- Overall global health improving, years lived with disability rising
-
- Post-exercise ABI linked to lower-extremity revascularization
- Screening older men may detect more abdominal aortic aneurysms
- Secondhand smoke exposure in utero, during childhood increased future AF risk
- Statin use increasingly common among very elderly patients
- TEXT ME: Program helps improve LDL, CVD risk factors in patients with CHD
- TTE appears viable for managing low-risk S. aureus bacteremia
- TULIP: CETP inhibitor well tolerated, effective for treatment of mild dyslipidemia
- Updated guidelines address new changes in PAD management
-
- Uric acid levels predict CV events in postmenopausal women
- Varenicline does not increase risk for cardiovascular, neuropsychiatric events
- ACC to launch clinical registries to track ablation, LAA occlusion procedures for AF
- SPRINT: Intensive BP management reduces CVD, mortality risk
- PCSK9 inhibitors change treatment approach for dyslipidemia Peter H. Jones, MD, FNLA
- AEGEAN: Adherence program does not provide additional value to apixaban users
- CIRCUS: Cyclosporine before PCI fails to improve outcomes after STEMI
- CUPID-2: Gene transfer fails to improve outcomes in HFrEF
-
- Jardiance reduces risk for CV death, all-cause mortality in adults with type 2 diabetes and CVD history
- Meta-analysis: Digoxin contributes to lower hospitalization, poses neutral effect on death
- OPTIDUAL: Extended DAPT not superior to 12-month therapy
- PRESERVATION I: Bioabsorbable cardiac matrix does not prevent LV remodeling, HF
- Two studies demonstrate noninferiority of bioresorbable vascular scaffold system
- VIDEO: CHAMPION-PHOENIX results indicate benefits of cangrelor, effect of access site during PCI
- A look at ezetimibe and the IMPROVE-IT trial Jessie Dunne, PharmD, BCPS; Sarah A. Spinler, PharmD, FCCP, FAHA, FASHP, AACC, BCPS (AQ Cardiology)
- Trial Scorecard: CALERIE
-
- Trial Scorecard: CIRCUS
- Trial Scorecard: DANTE
- Trial Scorecard: EXPAND
- Trial Scorecard: PATHWAY-2
- Trial Scorecard: PLATFORM
- Trial Scorecard: SERVE-HF
- Trial Scorecard: TULIP